Home Categories Biochemical Engineering Exendin-4
A3960112

Exendin-4 , 97%, 0-15%of acetic acid , 141758-74-9

CAS NO.:141758-74-9

Empirical Formula: C184H282N50O60S

Molecular Weight: 4186.57

MDL number: MFCD00240171

EINECS: 686-356-3

Pack Size Price Stock Quantity
1MG RMB559.20 In Stock
5mg RMB1959.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

RTECS  VT9545000
storage temp.  −20°C
solubility  ≥145 mg/mL in DMSO; insoluble in EtOH; ≥52 mg/mL in H2O with gentle warming
form  White to off-white solid.
color  White to off-white
Water Solubility  Soluble in water (1 mg/ml)
InChIKey HTQBXNHDCUEHJF-AAPNSGCPNA-N

Description and Uses

Exenatide is the first drug in a new class of anti-diabetics known as the incretin mimetics, and it is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes who are taking metformin, a sulfonylurea, or both, but have not achieved adequate glycemic control. Exenatide is a functional analog of the human incretin Glucagon-Like Peptide-1 (GLP-1). GLP-1 is naturally released from cells in the GI tract in response to food intake and acts on its receptor on b-cells to potentiate glucose-stimulated insulin secretion. Exenatide is a long-acting agonist at the GLP-1 receptor. It is a synthetic version of a 39-amino acid peptide found in the salivary secretions of the Gila monster lizard.also moderates peak serum glucagon levels during hyperglycemic periods following meals, but does not interfere with glucagon release in response to hypoglycemia. The dosing regimen for exenatide is 5 or 10 mg twice daily, administered as a subcutaneous injection within an hour before morning and evening meals. Following subcutaneous administration, peak plasma concentrations of exenatide are reached in 2.1 h, and the plasma pharmacokinetic profile is dose proportional. The most common adverse events reported with exenatide include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, and dyspepsia.

Antidiabetic.

Safety

Symbol(GHS) 
GHS08
Signal word  Warning
Hazard statements  H361-H351
Precautionary statements  P201-P202-P281-P308+P313-P405-P501-P201-P202-P281-P308+P313-P405-P501
WGK Germany  3
HS Code  2933290000
Hazardous Substances Data 141758-74-9(Hazardous Substances Data)

RELATED PRODUCTS